Thioredoxin interacting protein (TXNIP) is an independent risk stratifier for breast ductal carcinoma in situ

Thioredoxin interacting protein (TXNIP) is an independent risk stratifier for breast ductal carcinoma in situ

Current clinicopathological parameters are useful predictors of breast ductal carcinoma in situ behaviour, but they are insufficient to define high risk patients for disease progression precisely. Thioredoxin interacting protein (TXNIP) is a key player of oxidative stress. This study aims to evaluat...

Full description

Bibliographic Details
Main Authors: Miligy, Islam, Gorringe, Kylie L., Toss, Michael S., Al-Kawaz, Abdubaqi, Simpson, Peter, Diez-Rogriguez, Maria, Nolan, Christopher C., Ellis, Ian O., Green, Andrew R., Rakha, Emad
Format: Article
Published: Nature Publishing Group 2018
Subjects:
Suctal carcinoma in situ; Predictor; Outcome; Progression; TXNIP
Immunohistochemistry
Online Access:https://eprints.nottingham.ac.uk/52002/

Internet

https://eprints.nottingham.ac.uk/52002/

Similar Items